Michelle E. Farkas, Ph.D.

Affiliations: 
Chemistry University of Massachusetts, Amherst, Amherst, MA 
Area:
Chemical Biology
Website:
https://elements.chem.umass.edu/farkasgroup/
Google:
"Michelle Farkas"
Mean distance: 7.36
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lin HH, Robertson KL, Bisbee HA, et al. (2020) Oncogenic and Circadian Effects of Small Molecules Directly and Indirectly Targeting the Core Circadian Clock. Integrative Cancer Therapies. 19: 1534735420924094
Jiang Y, Hardie J, Liu Y, et al. (2018) Nanocapsule-mediated cytosolic siRNA delivery for anti-inflammatory treatment. Journal of Controlled Release : Official Journal of the Controlled Release Society
Joshi BP, Hardie J, Farkas ME. (2018) Harnessing Biology to Deliver Therapeutic and Imaging Entities via Cell-Based Methods. Chemistry (Weinheim An Der Bergstrasse, Germany)
Aanei IL, ElSohly AM, Farkas ME, et al. (2016) Biodistribution of Antibody-MS2 Viral Capsid Conjugates in Breast Cancer Models. Molecular Pharmaceutics
ElSohly AM, Netirojjanakul C, Aanei IL, et al. (2015) Synthetically Modified Viral Capsids as Versatile Carriers for Use in Antibody-based Cell Targeting. Bioconjugate Chemistry
Farkas ME, Aanei IL, Behrens CR, et al. (2013) PET Imaging and biodistribution of chemically modified bacteriophage MS2. Molecular Pharmaceutics. 10: 69-76
Carrico ZM, Farkas ME, Zhou Y, et al. (2012) N-Terminal labeling of filamentous phage to create cancer marker imaging agents. Acs Nano. 6: 6675-80
Farkas ME, Li BC, Dose C, et al. (2009) DNA sequence selectivity of hairpin polyamide turn units. Bioorganic & Medicinal Chemistry Letters. 19: 3919-23
Dose C, Farkas ME, Chenoweth DM, et al. (2008) Next generation hairpin polyamides with (R)-3,4-diaminobutyric acid turn unit. Journal of the American Chemical Society. 130: 6859-66
Chou CJ, Farkas ME, Tsai SM, et al. (2008) Small molecules targeting histone H4 as potential therapeutics for chronic myelogenous leukemia. Molecular Cancer Therapeutics. 7: 769-78
See more...